Fusion Pharmaceuticals Inc. Patent Applications Pending
51 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2026-02-02: Application 19466577; Invention HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF; Applicant Fusion Pharmaceuticals Inc.; Status Notice of Allowance Mailed -- Application Received in Office of Publications.
- 2025-11-10: Application 19482779; Invention USE OF RADIOPHARMACEUTICALS FOR TREATMENT OF CANCER; Applicant FUSION PHARMACEUTICALS INC.; Status Application Undergoing Preexam Processing.
- 2025-10-13: Application 19474981; Invention PSMA-TARGETED RADIOPHARMACEUTICALS AND DNA DAMAGE RESPONSE INHIBITOR COMBINATION THERAPY; Applicant FUSION PHARMACEUTICALS INC.; Status Docketed New Case - Ready for Examination.
- 2025-01-17: Application 19030341; Invention HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF; Applicant Fusion Pharmaceuticals Inc.; Status Non Final Action Mailed.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | 19466577 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | Fusion Pharmaceuticals Inc. | Notice of Allowance Mailed -- Application Received in Office of Publications | US20260166158A1 | Brian H. WHITE Mark T. BILODEAU Ashis K. SAHA | United States United States United States | VAJDA, KRISTIN ANN |
| 2025-11-10 | 19482779 | USE OF RADIOPHARMACEUTICALS FOR TREATMENT OF CANCER | FUSION PHARMACEUTICALS INC. | Application Undergoing Preexam Processing | Peng GUO John RHODEN | United States United States | ||
| 2025-10-13 | 19474981 | PSMA-TARGETED RADIOPHARMACEUTICALS AND DNA DAMAGE RESPONSE INHIBITOR COMBINATION THERAPY | FUSION PHARMACEUTICALS INC. | Docketed New Case - Ready for Examination | US20260241048A1 | John R. FORBES Brigitte Lise THÉRIAULT Shekoufeh ALMASI Vishal Subramony GAYATHRI | Canada Canada Canada Canada | CENTRAL, DOCKET |
| 2025-01-17 | 19030341 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20250387492A1 | Mark T. Bilodeau Benoît Moreau Sudhakar Kadiyala Richard Wooster Brian H. White | United States United States United States United States United States | YOUNG, MICAH PAUL |
| 2024-12-04 | 18968741 | METHODS OF DOSING THERAPEUTIC AGENTS | Fusion Pharmaceuticals Inc. | Docketed New Case - Ready for Examination | US20260120837A1 | Peng Guo John Rhoden | United States United States | CENTRAL, DOCKET |
| 2024-07-26 | 18833850 | PSMA-TARGETED RADIOPHARMACEUTICALS AND CHECKPOINT INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20250114488A1 | Natalie Grinshtein Shekoufeh Almasi Saleemulla Mahammad | United States Canada Canada | CRAIG, KAILA ANGELIQUE |
| 2024-07-26 | 18833849 | NTSR1-TARGETED RADIOPHARMACEUTICALS AND DNA DAMAGE RESPONSE INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20250177581A1 | John R. Forbes Saleemulla Mahammad | Canada Canada | MOSHER, ERIC PARKER |
| 2024-07-26 | 18833848 | NTSR1-TARGETED RADIOPHARMACEUTICALS AND CHECKPOINT INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20250099633A1 | Natalie Grinshtein Saleemulla Mahammad Maria Audrey Jaline Llanto Broqueza | United States Canada Canada | STAGE, DOCKET |
| 2024-04-23 | 18703995 | METHODS OF TREATING CANCER | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20250001019A1 | Eric S. Burak James O'Leary John Rhoden | Canada United States United States | MOSHER, ERIC PARKER |
| 2024-04-23 | 18703994 | CLAUDIN 18.2-TARGETED COMPOUNDS AND USES THEREOF | Fusion Pharmaceuticals Inc. | Application Undergoing Preexam Processing | US20260151520A1 | Natalie Grinshtein John Richard Forbes Sonal Patel Ian R. Duffy Thomas I. Kostelnik | United States Canada Canada Canada Canada | |
| 2024-04-11 | PCTUS2024024155 | STEAP2-TARGETED COMPOUNDS AND USE THEREOF | FUSION PHARMACEUTICALS INC. ASTRAZENECA UK LIMITED ASTRAZENECA AB | RO PROCESSING COMPLETED-PLACED IN STORAGE | DARLENE ANNE MONLISH DAVID RODRIGUEZ CAICEDO WILLIAM LESLIE TURNBULL SALEEMULLA MAHAMMAD DEWALD VAN DYK VANESSA MARIE MUNIZ-MEDINA NATHANAEL DAVID SALLADA SAO FONG CHEUNG JEONG MIN HAN FRANK IRVIN COMER ASURAYYA WORREDE CHIEN-YING CHANG | United States Canada Canada Canada United States United States United States United States United States United States United States United States | ||
| 2023-12-15 | 18541618 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOX | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20240207455A1 | Stephan Klinz Diane-Charlotte Imbs Elodie Lewkowicz Sylvie Rolland Thomas Rohban John R. Forbes | United States France France France France Canada | DICKINSON, PAUL W |
| 2023-12-15 | 18541604 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND, GEMCITABINE AND NAB-PACLITAXEL | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20240197927A1 | Diane-Charlotte Imbs Elodie Lewkowicz Alexander McEwan Thomas Rohban Sylvie Rolland Daniel Stevens John R. Forbes | France France Canada France France United Kingdom Canada | MOSHER, ERIC PARKER |
| 2023-12-15 | 18541584 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND FOLFIRINOX | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20240207276A1 | Diane-Charlotte Imbs Elodie Lewkowicz Alexander McEwan Thomas Rohban Sylvie Rolland Daniel Stevens John R. Forbes | France France Canada France France United Kingdom Canada | BAEK, JONGHWAN NMN |
| 2023-12-15 | 18541534 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOLI | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20240216550A1 | Stephan Klinz Diane-Charlotte Imbs Elodie Lewkowicz Sylvie Rolland Thomas Rohban John R. Forbes | United States France France France France Canada | DONOHUE, SEAN R |
| 2023-12-07 | 18568234 | RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20240285818A1 | Eric Steven Burak Julie Metcalf John Fitzmaurice Valliant Meiduo Hu Natalie Grinshtein | Canada Canada Canada Canada United States | LIPPERT, JOHN WILLIAM |
| 2023-11-17 | 18512575 | 2,6-DICHLOROPHENYL ESTER COMPOUNDS AND USE THEREOF | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20240139333A1 | Matthew Guest Michael B. Johansen Stuart J. Mahoney | United States Canada Canada | YOO, SUN JAE |
| 2023-08-25 | PCTUS2023072918 | EXTRACELLULAR HSP90 (EHSP90)-TARGETED RADIOPHARMACEUTICALS AND USE THEREOF | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | CHRISTOPHER PAUL LEAMON HARI KRISHNA R. SANTHAPURAM IONTCHO R. VLAHOV WILLIAM LESLIE TURNBULL BRIGITTE LISE THÉRIAULT STUART JAMES MAHONEY SAMUEL KUNJUNJU KUTTY | United States United States United States Canada Canada Canada Canada | THOMAS, SHANE M | |
| 2023-06-06 | PCTUS2023067981 | METHODS OF DOSING THERAPEUTIC AGENTS | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | PENG GUO JOHN RHODEN | United States United States | KIM, HARRY CHONG HYUN | |
| 2023-04-14 | 63496279 | PSMA-TARGETED RADIOPHARMACEUTICALS AND DNA DAMAGE RESPONSE INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | Provisional Application Expired | John R. Forbes | Canada | ||
| 2022-12-20 | PCTUS2022082021 | EGFR-CMET-TARGETED COMPOUNDS AND USES THEREOF | FUSION PHARMACEUTICALS INC. ASTRAZENECA UK LIMITED | PCT - International Search Report Mailed to IB | FRANK IRVINE COMER SADAF AGHEVLIAN NATALIE GRINSHTEIN IAN R. DUFFY THOMAS I. KOSTELNIK ANDREW GRIER BUCHANAN YARIV MAZOR SRINATH KASTURIRANGAN QUN DU CHUNNING YANG | United States Canada United States Canada Canada United Kingdom United States United States United States United States | MATOS NEGRON, TAINA DEL MAR | |
| 2022-11-02 | PCTUS2022079137 | METHODS OF TREATING CANCER | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | ERIC S. BURAK JAMES O'LEARY JOHN RHODEN | Canada United States United States | MATOS NEGRON, TAINA DEL MAR | |
| 2022-08-26 | 63401227 | EXTRACELLULAR HSP90 (eHSP90)-TARGETED RADIOPHARMACEUTICALS AND USE THEREOF | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Christopher Paul Leamon Hari Krishna R. Santhapuram Iontcho R. Vlahov | United States United States United States | ||
| 2022-06-16 | PCTUS2022033845 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOX | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | STEPHAN KLINZ DIANE-CHARLOTTE IMBS JOHN R. FORBES SYLVIE ROLLAND THOMAS ROHBAN ELODIE LEWKOWICZ | United States France Canada France France France | KIM, HARRY CHONG HYUN | |
| 2022-06-16 | PCTUS2022033841 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOLI | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | STEPHAN KLINZ DIANE-CHARLOTTE IMBS JOHN R. FORBES SYLVIE ROLLAND THOMAS ROHBAN ELODIE LEWKOWICZ | United States France Canada France France France | KIM, HARRY CHONG HYUN | |
| 2022-06-10 | PCTUS2022033058 | RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | ERIC STEVEN BURAK JULIE METCALF JOHN FITZMAURICE VALLIANT MEIDUO HU NATALIE GRINSHTEIN | Canada Canada Canada Canada United States | KIM, HARRY CHONG HYUN | |
| 2022-06-06 | 63349256 | METHODS OF DOSING THERAPEUTIC AGENTS | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Peng Guo John Rhoden | United States United States | ||
| 2022-05-27 | PCTUS2022031314 | 2,6-DICHLOROPHENYL ESTER COMPOUNDS AND USE THEREOF | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | MATTHEW GUEST MICHAEL B. JOHANSEN STUART J. MAHONEY | United States Canada Canada | KIM, HARRY CHONG HYUN | |
| 2022-04-22 | PCTUS2022025933 | METHODS FOR TREATMENT OF CANCERS | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | ERIC S. BURAK RYAN W. SIMMS JOHN R. FORBES | Canada Canada Canada | KIM, HARRY CHONG HYUN | |
| 2021-11-02 | 63274802 | METHODS OF TREATING CANCER | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Eric S. Burak James O'Leary John Rhoden | Canada United States United States | ||
| 2021-10-01 | 17600692 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | Fusion Pharmaceuticals Inc. | Notice of Allowance Mailed -- Application Received in Office of Publications | US20220184217A1 | Brian H. White Mark T. Bilodeau Ashis K. Saha | United States United States United States | VAJDA, KRISTIN ANN |
| 2021-06-16 | 63211318 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOX | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Diane-Charlotte Imbs Stephan Klinz Elodie Lewkowicz Sylvie Rolland Thomas Rohban John R. Forbes | France United States France France France Canada | ||
| 2021-06-16 | 63211316 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOLI | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Diane-Charlotte Imbs Stephan Klinz Elodie Lewkowicz Sylvie Rolland Thomas Rohban John R. Forbes | France United States France France France Canada | ||
| 2021-06-11 | 63209736 | RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Eric Steven Burak Julie Metcalf Natalie Grinshtein Meiduo Hu John Fitzmaurice Valliant | Canada Canada Canada Canada Canada | ||
| 2021-05-27 | 63194008 | 2,6-DICHLOROPHENYL ESTER COMPOUNDS AND USE THEREOF | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Stuart J. Mahoney Michael B. Johansen Matt Guest | Canada Canada Canada | ||
| 2021-04-23 | 63179089 | METHODS FOR TREATMENT OF CANCERS | Fusion Pharmaceuticals Inc. | Provisional Application Expired | John R. Forbes Ryan W. Simms Eric S. Burak | Canada Canada United States | ||
| 2021-03-23 | PCTUS2021023755 | FGFR3-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOF | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | ERIC STEVEN BURAK NATALIE GRINSHTEIN MARC SCHWABISH | Canada United States United States | YOUNG, LEE W | |
| 2021-01-08 | PCTUS2021012697 | MACROCYCLIC CHELATES AND USES THEREOF | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | MICHAEL B. JOHANSEN ERIC S. BURAK RYAN W. SIMMS STUART J. MAHONEY MELISSA CHASSE MATHEW D. MORAN JOHN F. VALLIANT | Canada Canada Canada Canada Canada Canada Canada | YOUNG, LEE W | |
| 2021-01-08 | PCTUS2021012656 | SUSTAINED IMMUNOTHERAPY | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | MEIDUO HU SONAL PATEL JULIE METCALF ERIC STEVEN BURAK NATALIE GRINSHTEIN JOHN FITZMAURICE VALLIANT | Canada Canada Canada Canada Canada | THOMAS, SHANE M | |
| 2020-06-10 | 63037520 | SUSTAINED IMMUNOTHERAPY | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Eric Steven Burak Julie Metcalf Natalie Grinshtein Meiduo Hu John Fitzmaurice Valliant Sonal Patel | Canada Canada Canada Canada Canada Canada | ||
| 2020-03-23 | 62993622 | FGFR3-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOF | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Marc Schwabish Natalie Grinshtein Eric Steven Burak | United States Canada Canada | ||
| 2020-03-03 | PCTUS2020020846 | METHODS AND COMPOSITIONS FOR TREATING CANCER | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | GRAEME CURRIE | Canada | YOUNG, LEE W | |
| 2020-01-10 | 62959879 | RADIOIMMUNOCONJUGATES SUSTAINED IMMUNOTHERAPY | Fusion Pharmaceuticals, Inc. | Provisional Application Expired | Eric Steven Burak Julie Metcalf Natalie Grinshtein Meiduo Hu John Fitzmaurice Valliant Sonal Patel | Canada Canada Canada Canada Canada Canada | ||
| 2020-01-10 | 62959665 | MACROCYCLIC CHELATES AND USES THEREOF | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Stuart J. Mahoney Michael B. Johansen Matthew D. Moran Melissa Chassé Ryan W. Simms Eric S. Burak John F. Valliant | Canada Canada Canada Canada Canada Canada Canada | ||
| 2019-12-04 | 16619433 | RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | Non Final Action Mailed | US20220088231A1 | Eric Steven BURAK John Richard FORBES Meiduo HU John Fitzmaurice VALLIANT | Canada Canada Canada Canada | CRAIGO, BAHAR ALAWI |
| 2018-05-04 | PCTUS2018031233 | IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | ERIC STEVEN BURAK JOHN RICHARD FORBES JOHN FITZMAURICE VALLIANT RYAN WAYNE SIMMS MATTHEW DAVID BURR MORAN | Canada Canada Canada Canada Canada | THOMAS, SHANE M | |
| 2018-05-04 | PCTUS2018031228 | PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF | FUSION PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | ERIC STEVEN BURAK JOHN FITZMAURICE VALLIANT RYAN WAYNE SIMMS STUART JAMES MAHONEY | Canada Canada Canada Canada | YOUNG, LEE W | |
| 2017-08-15 | 62545945 | IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Eric Steven Burak John Richard Forbes Matthew David Burr Moran Ryan Wayne Simms John Fitzmaurice Valliant Alla Darwish | Canada United States Canada Canada Canada Canada | ||
| 2017-05-05 | 62502288 | IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Eric Steven BURAK John Richard FORBES Matthew David Burr MORAN Ryan Wayne SIMMS John Fitzmaurice VALLIANT Alla Darwish | Canada Canada Canada Canada Canada Canada | ||
| 2017-05-05 | 62502260 | PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF | Fusion Pharmaceuticals Inc. | Provisional Application Expired | Eric Steven BURAK Stuart James Mahoney Ryan Wayne Simms John Fitzmaurice Valliant Alla Darwish | Canada Canada Canada Canada Canada | ||
| 19505749 | PSMA-TARGETED RADIOPHARMACEUTICALS FOR TREATMENT OF CANCER | Fusion Pharmaceuticals Inc. | Application Undergoing Preexam Processing | Kevin ROLAND Ian Ruixiang DUFFY Rajiv BHALLA | Canada Canada Canada |